FKBP3 and lung adenocarcinoma: In order to verify the clinical value of the model, we finally examined the expression of FERMT2, FKBP3, SMAD9, GATA2 and ITIH4 in 30 lung adenocarcinoma tissues by immunohistochemistry, considering the availability of antibodies.